The Enterprise Value as of November 2024 (TTM) for Bellerophon Therapeutics, Inc. (BLPH) is -3709207.00

According to Bellerophon Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -3709207.00. This represents a change of -122.22% compared to the average of 16.70M of the last 4 quarters.

Bellerophon Therapeutics, Inc. (BLPH) Historical Enterprise Value (quarterly & annually)

How has BLPH Enterprise Value performed in the past?

The mean historical Enterprise Value of Bellerophon Therapeutics, Inc. over the last ten years is 348.18M. The current -3709207.00 Enterprise Value has changed -206.53% with respect to the historical average. Over the past ten years (40 quarters), BLPH's Enterprise Value was at its highest in in the September 2014 quarter at 1.71B. The Enterprise Value was at its lowest in in the June 2022 quarter at -4001095.27.

Bellerophon Therapeutics, Inc. (BLPH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bellerophon Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bellerophon Therapeutics, Inc. (BLPH) Average Enterprise Value

How has BLPH Enterprise Value performed in the past?

The current Enterprise Value of Bellerophon Therapeutics, Inc. (BLPH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Bellerophon Therapeutics, Inc. (BLPH) Enterprise Value vs. Peers

How is BLPH’s Enterprise Value compared to its peers?

Bellerophon Therapeutics, Inc.’s Enterprise Value is less than Bio-Path Holdings, Inc. (0), less than Catalyst Biosciences, Inc. (3.00M), less than Diffusion Pharmaceuticals Inc. (19.42M), less than Capricor Therapeutics, Inc. (-1447403.00), less than NextCure, Inc. (2.43B), less than Zura Bio Limited (11.01M), greater than Altamira Therapeutics Ltd. (-9969663.00), less than Immix Biopharma, Inc. (909.70K), less than Enveric Biosciences, Inc. (30.53M), less than Palisade Bio, Inc. (202.96K), greater than null (-4438971.00),

Build a custom stock screener for Bellerophon Therapeutics, Inc. (BLPH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bellerophon Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bellerophon Therapeutics, Inc. (BLPH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bellerophon Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.